Search

everythinglearnresearchcommunity

for

Search:↓

Cannabinoids like CBD and THC may help treat non-cancer skin diseases, but more research is needed.

The CNC® prosthetic system improved body image in breast cancer patients with hair loss from chemotherapy but did not significantly change their psychological wellbeing.

The Italian version of a relationship scale was adapted for cancer patients, showing some differences from the original and suggesting its use could improve therapy and treatment adherence.

Using 5-alpha reductase inhibitors may lower the risk of breast cancer in females.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Actinic keratosis is a sun-induced skin condition that can potentially turn into skin cancer and requires treatment to prevent malignancy.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

A woman with breast cancer developed a rare condition causing excessive fine hair growth on her face and body.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

The document concluded that there were no effective ways to prevent hair loss from chemotherapy but treatments were being explored.

A woman developed severe bladder inflammation after cancer treatment with Cytoxan.

The document explains breast development, common breast conditions, and their treatments.

Actinic keratosis is a sun-induced skin condition that can potentially turn into skin cancer and requires various treatments to prevent this.

High levels of ST14 and TMEFF1 proteins in ovarian cancer are linked to worse patient outcomes and may be a new treatment target.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

There is no clear recommendation for using selenium in cancer patients; it may be beneficial to correct low selenium levels before treatment.

A cancer patient died from a severe skin reaction after taking the drug cetuximab.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Sex hormones might influence bladder cancer development, and aromatase inhibitors could increase risk in postmenopausal women.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Compounds from Alpinia zerumbet may help with hair regrowth and cancer treatment by targeting PAK1.

There is an urgent need for better treatments for hair loss caused by chemotherapy.

European dermatologic treatments focus on lifestyle and psychosocial factors, use diverse methods like baths and climate therapy, and emphasize the importance of diet and supplements for skin health.

Hair follicles can be used to quickly assess drug effects in cancer treatment.

Some viruses can cause cancer by changing cell processes and avoiding the immune system; vaccines and targeted treatments help reduce these cancers.

Cancer therapy can cause various skin problems, including hair loss, skin darkening, painful hand-foot syndrome, and severe skin damage.